Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-27

Clinical Trial Update: Sevoflurane Sedation on Intra Cranial Pressure in Traumatic Brain Injury Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sevoflurane sedation to modulate intracranial pressure in patients with traumatic brain injury was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Brain Injury | Phase 2 | Status: TERMINATED